Time Trends in the Incidence and Causes of Blindness in Israel

To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008. Descriptive, retrospective population-based study. During the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	American journal of ophthalmology Ročník 153; číslo 2; s. 214 - 221.e1
Hlavní autoři:	Skaat, Alon, Chetrit, Angela, Belkin, Michael, Kinori, Michael, Kalter-Leibovici, Ofra
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New York, NY Elsevier Inc 01.02.2012 Elsevier
Témata:	Adolescent Adult Age Distribution Aged Aged, 80 and over Biological and medical sciences Blindness - epidemiology Blindness - etiology Cataract - epidemiology Child Child, Preschool Diabetic Retinopathy - epidemiology Eye Diseases Female Glaucoma Glaucoma - epidemiology Humans Incidence Infant Israel - epidemiology Macular Degeneration - epidemiology Male Medical sciences Middle Aged Miscellaneous Ophthalmology Registries - statistics & numerical data Retrospective Studies Sex Distribution Time Factors Vision disorders Visually Impaired Persons - statistics & numerical data Young Adult Asia Israel Eye disease Ophthalmology Vision disorder Cause Blindness Incidence
ISSN:	0002-9394, 1879-1891, 1879-1891
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008. Descriptive, retrospective population-based study. During the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and were reviewed retrospectively. Specific rates by age, gender, calendar year, and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models. The age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8 per 100 000 in 1999 to 16.6 per 100 000 in 2008. The decline mainly was attributable to a decreased incidence of blindness resulting from age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract. Contemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness.
AbstractList	Purpose To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008. Design Descriptive, retrospective population-based study. Methods During the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and were reviewed retrospectively. Specific rates by age, gender, calendar year, and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models. Results The age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8 per 100 000 in 1999 to 16.6 per 100 000 in 2008. The decline mainly was attributable to a decreased incidence of blindness resulting from age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract. Conclusions Contemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness. To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008.PURPOSETo evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008.Descriptive, retrospective population-based study.DESIGNDescriptive, retrospective population-based study.During the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and were reviewed retrospectively. Specific rates by age, gender, calendar year, and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models.METHODSDuring the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and were reviewed retrospectively. Specific rates by age, gender, calendar year, and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models.The age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8 per 100 000 in 1999 to 16.6 per 100 000 in 2008. The decline mainly was attributable to a decreased incidence of blindness resulting from age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract.RESULTSThe age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8 per 100 000 in 1999 to 16.6 per 100 000 in 2008. The decline mainly was attributable to a decreased incidence of blindness resulting from age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract.Contemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness.CONCLUSIONSContemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness. To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008. Descriptive, retrospective population-based study. During the decade of the study, 19 862 inhabitants of Israel were newly registered as legally blind. Data were retrieved from the 1999 to 2008 annual reports of the National Registry of the Blind in Israel and were reviewed retrospectively. Specific rates by age, gender, calendar year, and cause of blindness were calculated. Total and cause-specific annual age-standardized rates were calculated as well. Findings were evaluated by the use of Poisson regression models. The age-standardized rate of incidence of newly registered legal blindness at the end of the studied decade was half of that at the beginning, declining from 33.8 per 100 000 in 1999 to 16.6 per 100 000 in 2008. The decline mainly was attributable to a decreased incidence of blindness resulting from age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract. Contemporary interventions in ophthalmology combined with widely available universal free access to healthcare seem to be effective in causing a major reduction in the incidence of blindness.
Author	Skaat, Alon Chetrit, Angela Belkin, Michael Kalter-Leibovici, Ofra Kinori, Michael
Author_xml	– sequence: 1 givenname: Alon surname: Skaat fullname: Skaat, Alon email: skaatalon@gmail.com organization: Goldschleger Eye Institute, Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel – sequence: 2 givenname: Angela surname: Chetrit fullname: Chetrit, Angela organization: Unit of Cardiovascular Epidemiology, Gertner Institute for Epidemiology & Health Policy Research, Tel Hashomer, Israel – sequence: 3 givenname: Michael surname: Belkin fullname: Belkin, Michael organization: Goldschleger Eye Research Institute, Tel Aviv University, Tel Hashomer, Israel – sequence: 4 givenname: Michael surname: Kinori fullname: Kinori, Michael organization: Goldschleger Eye Institute, Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel – sequence: 5 givenname: Ofra surname: Kalter-Leibovici fullname: Kalter-Leibovici, Ofra organization: Unit of Cardiovascular Epidemiology, Gertner Institute for Epidemiology & Health Policy Research, Tel Hashomer, Israel
BackLink	http://igdc.huji.ac.il/home/Maagar/Details.aspx?AN=3258$$D View record in IGDC http://dx.doi.org/10.1016/j.ajo.2011.08.035$$D View full text (Access may be restricted) http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25596126$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22264945$$D View this record in MEDLINE/PubMed
BookMark	eNqFkkFv1DAQhS1URLeFH8AF5YI4JdiOHcdCqgQroCtV6oHlbDn2pHXI2oudIPXf47ALSJXanmxL33vjeTNn6MQHDwi9JrgimDTvh0oPoaKYkAq3Fa75M7QirZAlaSU5QSuMMS1lLdkpOktpyM9GMPECnVJKGyYZX6GLrdtBsY3gbSqcL6ZbKDbeOAveQKG9LdZ6TpCK0BefRueth_QH3KSoYXyJnvd6TPDqeJ6j718-b9eX5dX1183641VpuGimkgqhseiN5Fxzi41tgenGEhAEiOxE1xusGTMMGKOmIYCt5HK52xrqtq_P0buD7z6GnzOkSe1cMjCO2kOYk5JE5EINZpl8cyTnbgdW7aPb6Xin_racgbdHQCejxz7q3G76z3EuG0KbzJEDZ2JIKUL_DyFYLfGrQeX41RK_wq3K8WeNuKcxbtKTC36K2o2PKo_fdjfWqM51ows3Ue9vnVE15W0GPhwAyDH_chBVMm4ZknURzKRscI_aX9xTmzxMl_v_AXeQhjBHn-eniEpUYfVt2ZxlcQhZdkYsBvJhgyeK_wbz3s7K
CODEN	AJOPAA
CitedBy_id	crossref_primary_10_1007_s40123_024_00938_7 crossref_primary_10_1080_03007995_2018_1506022 crossref_primary_10_1186_s13584_018_0206_3 crossref_primary_10_1016_j_ajo_2022_03_010 crossref_primary_10_1177_25158414211072623 crossref_primary_10_1016_j_ajo_2012_09_017 crossref_primary_10_1371_journal_pone_0145375 crossref_primary_10_1177_11206721211018348 crossref_primary_10_1097_IAE_0000000000002768 crossref_primary_10_1016_S0140_6736_22_02609_5 crossref_primary_10_1001_jamaophthalmol_2020_3989 crossref_primary_10_1007_s00347_020_01267_3 crossref_primary_10_1016_j_ophtha_2016_07_037 crossref_primary_10_1186_s13104_015_1770_z crossref_primary_10_1136_bjophthalmol_2013_303394 crossref_primary_10_1371_journal_pone_0101072 crossref_primary_10_1007_s00347_016_0224_x crossref_primary_10_1038_eye_2015_48 crossref_primary_10_1111_aos_12540 crossref_primary_10_1136_bjophthalmol_2013_303233 crossref_primary_10_1111_aos_15721 crossref_primary_10_1517_14740338_2014_939951 crossref_primary_10_1016_j_ophtha_2016_06_053 crossref_primary_10_1089_tmj_2021_0098 crossref_primary_10_1016_j_oftal_2022_02_006 crossref_primary_10_1007_s00417_014_2885_y crossref_primary_10_4103_2320_3897_174429 crossref_primary_10_1007_s00417_021_05451_2 crossref_primary_10_3390_life13020385 crossref_primary_10_1016_j_ophtha_2017_05_035 crossref_primary_10_17116_oftalma2024140022172 crossref_primary_10_1007_s00347_015_0062_2 crossref_primary_10_1016_j_diabres_2016_05_002 crossref_primary_10_3389_fmed_2018_00125 crossref_primary_10_1186_s12979_019_0160_0 crossref_primary_10_1097_MD_0000000000000505 crossref_primary_10_1111_aos_13187 crossref_primary_10_1038_eye_2014_296 crossref_primary_10_1016_j_exer_2018_06_024 crossref_primary_10_1016_j_ophtha_2015_12_030 crossref_primary_10_1038_s41433_018_0300_3 crossref_primary_10_1097_APO_0000000000000415 crossref_primary_10_1016_j_oftale_2022_05_006 crossref_primary_10_1016_j_ophtha_2017_11_036 crossref_primary_10_1097_ICU_0000000000000050 crossref_primary_10_1016_j_jep_2020_112773 crossref_primary_10_1186_s12886_017_0603_3 crossref_primary_10_1007_s00417_021_05091_6 crossref_primary_10_1016_j_jcjo_2015_11_002 crossref_primary_10_1177_2284240318793905 crossref_primary_10_1111_aos_12680 crossref_primary_10_1016_S2213_8587_16_30010_9 crossref_primary_10_1111_aos_16763 crossref_primary_10_1371_journal_pone_0220983 crossref_primary_10_1186_s12886_020_01554_2 crossref_primary_10_1016_j_ajo_2011_11_022 crossref_primary_10_3109_09286586_2015_1066396 crossref_primary_10_1016_j_oret_2017_01_004 crossref_primary_10_1007_s00417_020_04885_4 crossref_primary_10_1038_s41433_024_02943_3 crossref_primary_10_1007_s00404_014_3412_4 crossref_primary_10_1097_IAE_0000000000001501 crossref_primary_10_3760_cma_j_issn_0366_6999_20140017 crossref_primary_10_1038_eye_2016_149 crossref_primary_10_1016_j_ajo_2018_12_008 crossref_primary_10_1111_aos_12272 crossref_primary_10_1016_j_ajo_2013_02_012 crossref_primary_10_1111_aos_15224 crossref_primary_10_1016_j_jaapos_2015_04_002 crossref_primary_10_1016_j_ophtha_2013_05_018 crossref_primary_10_1016_j_oret_2019_10_019 crossref_primary_10_3109_09286586_2015_1090004
Cites_doi	10.1076/opep.10.4.267.15910 10.1016/S0161-6420(03)00579-7 10.1076/opep.11.2.67.28158 10.1038/nrd1381 10.1097/01.ijg.0000151889.59165.3d 10.1016/j.ophtha.2008.08.012 10.1167/iovs.02-0304 10.1111/j.1475-1313.2011.00849.x 10.1007/s10792-008-9278-3 10.2337/dc09-0615 10.1136/bjo.87.3.282 10.1136/bmj.c2459 10.1080/09286580500473779 10.1056/NEJMoa1102673 10.1038/eye.2010.122 10.2165/00002512-200825100-00005 10.1093/qjmed/hcm150 10.1016/S0140-6736(05)74588-8 10.1001/archophthalmol.2011.140 10.1097/ICU.0b013e3283459724
ContentType	Journal Article
Copyright	2012 Elsevier Inc. Elsevier Inc. 2015 INIST-CNRS Copyright © 2012 Elsevier Inc. All rights reserved.
Copyright_xml	– notice: 2012 Elsevier Inc. – notice: Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2012 Elsevier Inc. All rights reserved.
DBID	AGDVQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.ajo.2011.08.035
DatabaseName	IGDC Bibliographic Database - מאגר לחקר ההזדקנות CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	IGDC Bibliographic Database CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1879-1891
EndPage	221.e1
ExternalDocumentID	22264945 25596126 10_1016_j_ajo_2011_08_035 3258 S0002939411006775 1_s2_0_S0002939411006775
Genre	Journal Article
GeographicLocations	Asia Israel
GeographicLocations_xml	– name: Israel
GroupedDBID	--- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 1B1 1CY 1P~ 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ AABNK AAEDT AAEDW AAHTB AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABCQX ABDPE ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABOCM ABPEJ ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACLOT ACNCT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHMBA AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CS3 EBS EFJIC EFKBS EFLBG EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N4W N9A O-L O9- OAUVE OF- OPF OQ~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SCC SDF SDG SDP SEL SES SPCBC SSH SSZ SV3 T5K UNMZH UV1 VH1 WH7 WOW X7M XPP Z5R ZGI ZXP ~G- ~HD 3V. 7RV 7X7 8FI AACTN AFCTW AFKRA AFKWA AJOXV AMFUW AZQEC BENPR FYUFA GUQSH M1P M2O PKN RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU G8K LCYCR ZA5 AGCQF AGDVQ 9DU AAYXX CITATION AGRNS IQODW CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c576t-277a07fc955a5d0cd8e4a6d1e71e19b7bfc0a44c4e442c61e0d959442cd3e38f3
ISICitedReferencesCount	90
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000299717800005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0002-9394 1879-1891
IngestDate	Sun Nov 09 14:47:56 EST 2025 Mon Jul 21 06:00:17 EDT 2025 Mon Jul 21 09:14:11 EDT 2025 Sat Nov 29 07:30:04 EST 2025 Tue Nov 18 21:37:18 EST 2025 Mon Aug 25 03:15:53 EDT 2025 Fri Feb 23 02:29:06 EST 2024 Sun Feb 23 10:19:45 EST 2025 Tue Oct 14 19:30:44 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	Eye disease Ophthalmology Vision disorder Cause Blindness Incidence
Language	English
License	CC BY 4.0 Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c576t-277a07fc955a5d0cd8e4a6d1e71e19b7bfc0a44c4e442c61e0d959442cd3e38f3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	22264945
PQID	917576604
PQPubID	23479
PageCount	8
ParticipantIDs	proquest_miscellaneous_917576604 pubmed_primary_22264945 pascalfrancis_primary_25596126 crossref_primary_10_1016_j_ajo_2011_08_035 crossref_citationtrail_10_1016_j_ajo_2011_08_035 igdc_bibliographic_3258 elsevier_sciencedirect_doi_10_1016_j_ajo_2011_08_035 elsevier_clinicalkeyesjournals_1_s2_0_S0002939411006775 elsevier_clinicalkey_doi_10_1016_j_ajo_2011_08_035
PublicationCentury	2000
PublicationDate	2012-02-01
PublicationDateYYYYMMDD	2012-02-01
PublicationDate_xml	– month: 02 year: 2012 text: 2012-02-01 day: 01
PublicationDecade	2010
PublicationPlace	New York, NY
PublicationPlace_xml	– name: New York, NY – name: United States
PublicationTitle	American journal of ophthalmology
PublicationTitleAlternate	Am J Ophthalmol
PublicationYear	2012
Publisher	Elsevier Inc Elsevier
Publisher_xml	– name: Elsevier Inc – name: Elsevier
References	Bressler N.M., Doan Q.V., Varma R., et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol;129(6):709–717. Kaiserman, Kaiserman, Nakar, Vinker (bib18) 2005; 14 Chew, Ferris, Csaky (bib24) 2003; 110 Bunce C., Xing W., Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008. Eye (Lond);24(11):1692–1699. Trautner, Haastert, Richter (bib6) 2003; 44 Weitzman, Greenfield, Billimek (bib21) 2009; 11 Mansur, Weiss, Hoffman (bib19) 2008; 25 Avisar, Friling, Snir (bib11) 2006; 8 Ahmad (bib3) 2000; 355 Ferrara, Hillan, Gerber, Novotny (bib15) 2004; 3 Witkin A.J., Brown G.C. Update on nonsurgical therapy for diabetic macular edema. Curr Opin Ophthalmol;22(3):185–189. Kvanta, Algvere, Berglin, Seregard (bib12) 1996; 37 Ip, Scott, Brown (bib14) 2008; 115 Tufail A., Patel P.J., Egan C., et al. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ;340:c2459. Vinker, Nakar, Ram (bib23) 2005; 7 O'Colmain U., Anijeet D., Vosoughi M., et al. Glaucoma blind registration in Fife (2000–2009)—a retrospective cohort study. Ophthalmic Physiol Opt;31(4):360–366. Wong, Mwamburi, Klein (bib20) 2009; 32 Guerin, Flynn, Brady, Colm (bib27) 2008; 29 Avisar, Bahar, Weinberger (bib10) 2003; 142 (bib9) 1990; 43 Pascolini, Mariotti, Pokharel (bib2) 2004; 11 Asleh, Chowers (bib29) 2007; 9 Babalola, Murdoch, Cousens (bib28) 2003; 87 Farber (bib4) 2003; 10 Yong, Morgan, Cooper (bib8) 2006; 13 Elis, Rosenmann, Chodick (bib22) 2008; 101 Kleinmann, Asia (bib26) 2010; 11 Martin D.F., Maguire M.G., Ying G.S., et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med;364(20):1897–1908. Resnikoff, Pascolini, Etya'ale (bib1) 2004; 82 (10.1016/j.ajo.2011.08.035_bib9) 1990; 43 Mansur (10.1016/j.ajo.2011.08.035_bib19) 2008; 25 Vinker (10.1016/j.ajo.2011.08.035_bib23) 2005; 7 Avisar (10.1016/j.ajo.2011.08.035_bib11) 2006; 8 Resnikoff (10.1016/j.ajo.2011.08.035_bib1) 2004; 82 Chew (10.1016/j.ajo.2011.08.035_bib24) 2003; 110 Asleh (10.1016/j.ajo.2011.08.035_bib29) 2007; 9 10.1016/j.ajo.2011.08.035_bib25 Guerin (10.1016/j.ajo.2011.08.035_bib27) 2008; 29 Wong (10.1016/j.ajo.2011.08.035_bib20) 2009; 32 Kleinmann (10.1016/j.ajo.2011.08.035_bib26) 2010; 11 Ahmad (10.1016/j.ajo.2011.08.035_bib3) 2000; 355 Elis (10.1016/j.ajo.2011.08.035_bib22) 2008; 101 Pascolini (10.1016/j.ajo.2011.08.035_bib2) 2004; 11 10.1016/j.ajo.2011.08.035_bib5 10.1016/j.ajo.2011.08.035_bib7 Ip (10.1016/j.ajo.2011.08.035_bib14) 2008; 115 Ferrara (10.1016/j.ajo.2011.08.035_bib15) 2004; 3 Babalola (10.1016/j.ajo.2011.08.035_bib28) 2003; 87 Kaiserman (10.1016/j.ajo.2011.08.035_bib18) 2005; 14 Farber (10.1016/j.ajo.2011.08.035_bib4) 2003; 10 Weitzman (10.1016/j.ajo.2011.08.035_bib21) 2009; 11 Trautner (10.1016/j.ajo.2011.08.035_bib6) 2003; 44 10.1016/j.ajo.2011.08.035_bib16 10.1016/j.ajo.2011.08.035_bib17 Avisar (10.1016/j.ajo.2011.08.035_bib10) 2003; 142 Yong (10.1016/j.ajo.2011.08.035_bib8) 2006; 13 Kvanta (10.1016/j.ajo.2011.08.035_bib12) 1996; 37 10.1016/j.ajo.2011.08.035_bib13
References_xml	– volume: 44 start-page: 1031 year: 2003 end-page: 1034 ident: bib6 article-title: Incidence of blindness in southern Germany due to glaucoma and degenerative conditions publication-title: Invest Ophthalmol Vis Sci – volume: 25 start-page: 861 year: 2008 end-page: 870 ident: bib19 article-title: Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study publication-title: Drugs Aging – reference: Martin D.F., Maguire M.G., Ying G.S., et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med;364(20):1897–1908. – volume: 355 start-page: 1528 year: 2000 ident: bib3 article-title: WHO programme gives hope to blind and partially sighted people in Africa publication-title: Lancet – volume: 3 start-page: 391 year: 2004 end-page: 400 ident: bib15 article-title: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer publication-title: Nat Rev Drug Discov – volume: 110 start-page: 1683 year: 2003 end-page: 1689 ident: bib24 article-title: The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study publication-title: Ophthalmology – reference: O'Colmain U., Anijeet D., Vosoughi M., et al. Glaucoma blind registration in Fife (2000–2009)—a retrospective cohort study. Ophthalmic Physiol Opt;31(4):360–366. – reference: Tufail A., Patel P.J., Egan C., et al. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ;340:c2459. – volume: 13 start-page: 35 year: 2006 end-page: 42 ident: bib8 article-title: Trends in registered blindness and its causes over 19 years in Western Australia publication-title: Ophthalmic Epidemiol – reference: Bunce C., Xing W., Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007–March 2008. Eye (Lond);24(11):1692–1699. – volume: 11 start-page: 67 year: 2004 end-page: 115 ident: bib2 article-title: 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies publication-title: Ophthalmic Epidemiol – reference: Bressler N.M., Doan Q.V., Varma R., et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol;129(6):709–717. – volume: 32 start-page: 2307 year: 2009 end-page: 2313 ident: bib20 article-title: Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis publication-title: Diabetes Care – volume: 14 start-page: 157 year: 2005 end-page: 160 ident: bib18 article-title: The effect of combination pharmacotherapy on the prescription trends of glaucoma medications publication-title: J Glaucoma – volume: 7 start-page: 643 year: 2005 end-page: 647 ident: bib23 article-title: Quality of diabetes care in the community: a cross-sectional study in central Israel publication-title: Isr Med Assoc J – volume: 82 start-page: 844 year: 2004 end-page: 851 ident: bib1 article-title: Global data on visual impairment in the year 2002 publication-title: Bull World Health Organ – volume: 9 start-page: 656 year: 2007 end-page: 658 ident: bib29 article-title: Ethnic background as a risk factor for advanced age-related macular degeneration in Israel publication-title: Isr Med Assoc J – volume: 10 start-page: 267 year: 2003 end-page: 277 ident: bib4 article-title: National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness publication-title: Ophthalmic Epidemiol – volume: 11 start-page: 719 year: 2009 end-page: 724 ident: bib21 article-title: Improving combined diabetes outcomes by adding a simple patient intervention to physician feedback: a cluster randomized trial publication-title: Isr Med Assoc J – volume: 115 start-page: 1837 year: 2008 end-page: 1846 ident: bib14 article-title: Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology publication-title: Ophthalmology – reference: Witkin A.J., Brown G.C. Update on nonsurgical therapy for diabetic macular edema. Curr Opin Ophthalmol;22(3):185–189. – volume: 29 start-page: 511 year: 2008 end-page: 516 ident: bib27 article-title: Worldwide geographical distribution of ophthalmology publications publication-title: Int Ophthalmol – volume: 43 start-page: 204 year: 1990 end-page: 245 ident: bib9 article-title: Strengthening of Epidemiological and Statistical Services Unit publication-title: World Health Stat Q – volume: 87 start-page: 282 year: 2003 end-page: 284 ident: bib28 article-title: Blindness: how to assess numbers and causes? publication-title: Br J Ophthalmol – volume: 142 start-page: 94 year: 2003 end-page: 96 ident: bib10 article-title: Causes of blindness in the year 2000 in Israel publication-title: Harefuah – volume: 8 start-page: 880 year: 2006 end-page: 881 ident: bib11 article-title: Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998–2003 publication-title: Isr Med Assoc J – volume: 11 start-page: 30 year: 2010 end-page: 32 ident: bib26 article-title: Epidemiology of cataract surgeries in Israel: 2 decade review (1990–2009) publication-title: Israel Journal of Eye Update – volume: 101 start-page: 275 year: 2008 end-page: 280 ident: bib22 article-title: The association between glycemic, lipids and blood pressure control among Israeli diabetic patients publication-title: QJM – volume: 37 start-page: 1929 year: 1996 end-page: 1934 ident: bib12 article-title: Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor publication-title: Invest Ophthalmol Vis Sci – volume: 142 start-page: 94 issue: 2 year: 2003 ident: 10.1016/j.ajo.2011.08.035_bib10 article-title: Causes of blindness in the year 2000 in Israel publication-title: Harefuah – volume: 10 start-page: 267 issue: 4 year: 2003 ident: 10.1016/j.ajo.2011.08.035_bib4 article-title: National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness publication-title: Ophthalmic Epidemiol doi: 10.1076/opep.10.4.267.15910 – volume: 8 start-page: 880 issue: 12 year: 2006 ident: 10.1016/j.ajo.2011.08.035_bib11 article-title: Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998–2003 publication-title: Isr Med Assoc J – volume: 110 start-page: 1683 issue: 9 year: 2003 ident: 10.1016/j.ajo.2011.08.035_bib24 article-title: The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study publication-title: Ophthalmology doi: 10.1016/S0161-6420(03)00579-7 – volume: 11 start-page: 67 issue: 2 year: 2004 ident: 10.1016/j.ajo.2011.08.035_bib2 article-title: 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies publication-title: Ophthalmic Epidemiol doi: 10.1076/opep.11.2.67.28158 – volume: 3 start-page: 391 issue: 5 year: 2004 ident: 10.1016/j.ajo.2011.08.035_bib15 article-title: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1381 – volume: 11 start-page: 30 year: 2010 ident: 10.1016/j.ajo.2011.08.035_bib26 article-title: Epidemiology of cataract surgeries in Israel: 2 decade review (1990–2009) publication-title: Israel Journal of Eye Update – volume: 14 start-page: 157 issue: 2 year: 2005 ident: 10.1016/j.ajo.2011.08.035_bib18 article-title: The effect of combination pharmacotherapy on the prescription trends of glaucoma medications publication-title: J Glaucoma doi: 10.1097/01.ijg.0000151889.59165.3d – volume: 37 start-page: 1929 issue: 9 year: 1996 ident: 10.1016/j.ajo.2011.08.035_bib12 article-title: Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor publication-title: Invest Ophthalmol Vis Sci – volume: 115 start-page: 1837 issue: 10 year: 2008 ident: 10.1016/j.ajo.2011.08.035_bib14 article-title: Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology publication-title: Ophthalmology doi: 10.1016/j.ophtha.2008.08.012 – volume: 43 start-page: 204 issue: 4 year: 1990 ident: 10.1016/j.ajo.2011.08.035_bib9 article-title: Strengthening of Epidemiological and Statistical Services Unit publication-title: World Health Stat Q – volume: 44 start-page: 1031 issue: 3 year: 2003 ident: 10.1016/j.ajo.2011.08.035_bib6 article-title: Incidence of blindness in southern Germany due to glaucoma and degenerative conditions publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.02-0304 – ident: 10.1016/j.ajo.2011.08.035_bib7 doi: 10.1111/j.1475-1313.2011.00849.x – volume: 11 start-page: 719 issue: 12 year: 2009 ident: 10.1016/j.ajo.2011.08.035_bib21 article-title: Improving combined diabetes outcomes by adding a simple patient intervention to physician feedback: a cluster randomized trial publication-title: Isr Med Assoc J – volume: 29 start-page: 511 issue: 6 year: 2008 ident: 10.1016/j.ajo.2011.08.035_bib27 article-title: Worldwide geographical distribution of ophthalmology publications publication-title: Int Ophthalmol doi: 10.1007/s10792-008-9278-3 – volume: 32 start-page: 2307 issue: 12 year: 2009 ident: 10.1016/j.ajo.2011.08.035_bib20 article-title: Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis publication-title: Diabetes Care doi: 10.2337/dc09-0615 – volume: 87 start-page: 282 issue: 3 year: 2003 ident: 10.1016/j.ajo.2011.08.035_bib28 article-title: Blindness: how to assess numbers and causes? publication-title: Br J Ophthalmol doi: 10.1136/bjo.87.3.282 – volume: 82 start-page: 844 issue: 11 year: 2004 ident: 10.1016/j.ajo.2011.08.035_bib1 article-title: Global data on visual impairment in the year 2002 publication-title: Bull World Health Organ – ident: 10.1016/j.ajo.2011.08.035_bib16 doi: 10.1136/bmj.c2459 – volume: 7 start-page: 643 issue: 10 year: 2005 ident: 10.1016/j.ajo.2011.08.035_bib23 article-title: Quality of diabetes care in the community: a cross-sectional study in central Israel publication-title: Isr Med Assoc J – volume: 13 start-page: 35 issue: 1 year: 2006 ident: 10.1016/j.ajo.2011.08.035_bib8 article-title: Trends in registered blindness and its causes over 19 years in Western Australia publication-title: Ophthalmic Epidemiol doi: 10.1080/09286580500473779 – ident: 10.1016/j.ajo.2011.08.035_bib13 doi: 10.1056/NEJMoa1102673 – ident: 10.1016/j.ajo.2011.08.035_bib5 doi: 10.1038/eye.2010.122 – volume: 25 start-page: 861 issue: 10 year: 2008 ident: 10.1016/j.ajo.2011.08.035_bib19 article-title: Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study publication-title: Drugs Aging doi: 10.2165/00002512-200825100-00005 – volume: 101 start-page: 275 issue: 4 year: 2008 ident: 10.1016/j.ajo.2011.08.035_bib22 article-title: The association between glycemic, lipids and blood pressure control among Israeli diabetic patients publication-title: QJM doi: 10.1093/qjmed/hcm150 – volume: 355 start-page: 1528 issue: 9214 year: 2000 ident: 10.1016/j.ajo.2011.08.035_bib3 article-title: WHO programme gives hope to blind and partially sighted people in Africa publication-title: Lancet doi: 10.1016/S0140-6736(05)74588-8 – ident: 10.1016/j.ajo.2011.08.035_bib17 doi: 10.1001/archophthalmol.2011.140 – volume: 9 start-page: 656 issue: 9 year: 2007 ident: 10.1016/j.ajo.2011.08.035_bib29 article-title: Ethnic background as a risk factor for advanced age-related macular degeneration in Israel publication-title: Isr Med Assoc J – ident: 10.1016/j.ajo.2011.08.035_bib25 doi: 10.1097/ICU.0b013e3283459724
SSID	ssj0006747
Score	2.3563004
Snippet	To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008. Descriptive, retrospective population-based... Purpose To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008. Design Descriptive, retrospective... To evaluate time trends in the incidence and causes of new cases of blindness in Israel between 1999 and 2008.PURPOSETo evaluate time trends in the incidence...
SourceID	proquest pubmed pascalfrancis crossref igdc elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	214
SubjectTerms	Adolescent Adult Age Distribution Aged Aged, 80 and over Biological and medical sciences Blindness - epidemiology Blindness - etiology Cataract - epidemiology Child Child, Preschool Diabetic Retinopathy - epidemiology Eye Diseases Female Glaucoma Glaucoma - epidemiology Humans Incidence Infant Israel - epidemiology Macular Degeneration - epidemiology Male Medical sciences Middle Aged Miscellaneous Ophthalmology Registries - statistics & numerical data Retrospective Studies Sex Distribution Time Factors Vision disorders Visually Impaired Persons - statistics & numerical data Young Adult
Title	Time Trends in the Incidence and Causes of Blindness in Israel
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0002939411006775 https://www.clinicalkey.es/playcontent/1-s2.0-S0002939411006775 https://dx.doi.org/10.1016/j.ajo.2011.08.035 http://igdc.huji.ac.il/home/Maagar/Details.aspx?AN=3258 https://www.ncbi.nlm.nih.gov/pubmed/22264945 https://www.proquest.com/docview/917576604
Volume	153
WOSCitedRecordID	wos000299717800005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1879-1891 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006747 issn: 0002-9394 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DiFeENdRLlUeeAKlih07jl-QRlXEuExIG6hvlpM4a0qWVk077Yfwgzmuc2nHOi4SL1GU-jSOz-djH_v4Owi9VEQzrBV2U4J9l0ZKuCpKmUvB6SE4wYlaLw18-8SPj8PxWHzpdH7UZ2Eucl4U4eWlmP9XVcMzULY5OvsX6m7-FB7APSgdrqB2uP6Z4rNz_boNdbXRkbHNHbreKhiqVWmpZt_CHDNZ2zooeFQu6vj5mpW23s3ZoJeYzSfLicrPt1bjT74rZekL8nZXfzgxybrsYxM523r-Oq9ygG3G7Nv8KjN78H3zh2pJwsR2NOEdrZkVvs1e3JhZSwpc4YlsGU26Mf4SggcaX2vd7ULDdKCms5Z81bKdbDNpj4YfsVuSgeeemLqYqhhqvIDzK4WtHyRLIj35S9E9tE84E2Ar9w-PRuMPzQgfcMprt8oI1Lvl67jBK5XbNd_pZmdJbCJxVQmdMbVZVHa7Oevpzuk9dLfyU5xDi6_7qKOLB-j25yoS4yF6Y2DmWJg5WeEAzJwGZg7AzLEwc2ap08DMFLQwe4S-vhudDt-7VS4ONwaPdOkSzpXH01gwpljixUmoqQoSrDnWWEQ8SmNPURpTTSmJA6y9RDBh7hNf-2HqP0bdYlboJ8gRWIUhTQiNjO9PVCgYiXSUsFR7YFJoD3l1i8m4Iqo3-VJyWUckTiU0sjSNLE0OVZ_10KtGZG5ZWm4qTGo1yPr4MQyYElB2kxC_TkiXVQ8s5S4U9RBtJKtZrZ2t_u6FBwYhMsqiPLPs9VksfcLCHupvgab5YrM6AA5L0ENOjSIJg4XZAVSFnq1KKcBZ4EHgQRsfWHS1wuZEvaDs6T9_6DN0pzUGz1F3uVjpF-hWfLHMykUf7fFx2K960k_1yefO
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Time+Trends+in+the+Incidence+and+Causes+of+Blindness+in+Israel&rft.jtitle=American+journal+of+ophthalmology&rft.au=Skaat%2C+Alon&rft.au=Chetrit%2C+Angela&rft.au=Belkin%2C+Michael&rft.au=Kinori%2C+Michael&rft.date=2012-02-01&rft.issn=0002-9394&rft.volume=153&rft.issue=2&rft.spage=214&rft.epage=221.e1&rft_id=info:doi/10.1016%2Fj.ajo.2011.08.035&rft.externalDBID=ECK1-s2.0-S0002939411006775&rft.externalDocID=1_s2_0_S0002939411006775
thumbnail_m	http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029394%2FS0002939411X00132%2Fcov150h.gif